表紙:創薬サービスの世界市場規模調査&予測、プロセス別、タイプ別、薬剤タイプ別、治療領域別、エンドユーザー別、地域別分析、2023-2030年
市場調査レポート
商品コード
1334581

創薬サービスの世界市場規模調査&予測、プロセス別、タイプ別、薬剤タイプ別、治療領域別、エンドユーザー別、地域別分析、2023-2030年

Global Drug Discovery Services Market Size study & Forecast, by Process, by Type, by Drug Type, by Therapeutic Area, by End User, and Regional Analysis, 2023-2030

出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
創薬サービスの世界市場規模調査&予測、プロセス別、タイプ別、薬剤タイプ別、治療領域別、エンドユーザー別、地域別分析、2023-2030年
出版日: 2023年08月10日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の創薬サービス市場は、2022年に約179億米ドルと評価され、予測期間2023-2030年には14.9%以上の健全な成長率で成長すると予測されています。

創薬サービスには、新薬候補の同定、開発、最適化を支援するために専門機関が提供する科学的・技術的ソリューションの範囲が含まれます。これらのサービスには、標的の同定と検証、ハイスループットスクリーニング、ヒットからリードへの最適化、医薬品化学、ADME(吸収・分布・代謝・排泄)研究、前臨床開発など、創薬プロセスのさまざまな段階が含まれます。専門知識、先端技術、調査手法を組み合わせることで、創薬サービスは安全で有効な医薬品の発見と開発を加速し、最終的にはヘルスケアを発展させ、アンメットニーズに応えることを目指しています。市場成長を促進する要因は、研究開発費の増加と慢性疾患の蔓延です。

Statistaによると、2022年の医薬品研究開発への総支出は2,380億米ドルで、2028年には2,850億米ドルに達すると予想されています。がん、心血管疾患、神経疾患などの慢性疾患の罹患率が上昇しているため、革新的で効果的な薬物療法に対するニーズが高まっています。Statistaによると、世界のがん死亡者数は2022年の約1,000万人から2040年には1,600万人を超えると予測されています。さらに、生物製剤や細胞ベースの治療法の拡大、個別化医薬品の需要の高まりは、有利な機会を生み出す可能性があります。しかし、創薬コストの高さと熟練労働力の限られた利用可能性が、2023-2030年の予測期間を通じて市場の成長を阻害しています。

創薬サービスの世界市場調査において考慮した主要地域は、アジア太平洋、北米、欧州、ラテンアメリカ、中東・アフリカです。北米は、確立された製薬部門、進行中の研究開発プロジェクト、多額の研究開発費、バイオシミラーおよびジェネリック医薬品市場の拡大、製薬・バイオ製薬企業による研究開発サービスのアウトソーシング増加により、2022年の市場を独占しました。しかし、アジア太平洋地域は、製薬業界の成長、業務の合理化、コスト削減、専門的な専門知識へのアクセスを目的とした専門サービスプロバイダーへの創薬活動のアウトソーシングの増加などの要因により、予測期間中に最も急成長することが予想されます。

本調査の目的は、近年におけるさまざまなセグメントと国の市場規模を明らかにし、今後数年間の市場規模を予測することです。本レポートは、調査対象国における業界の質的・量的側面の両方を盛り込むよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場における潜在的な機会も組み込んでいます。

目次

第1章 エグゼクティブサマリー

第2章 世界の創薬サービス市場の定義と範囲

  • 調査目的
  • 市場の定義と範囲
    • 業界の進化
    • 調査範囲
  • 調査対象年
  • 通貨換算レート

第3章 世界の創薬サービス市場力学

  • 創薬サービス市場の影響分析(2020年~2030年)
    • 市場促進要因
      • 研究開発費の増加
      • 慢性疾患の増加
    • 市場の課題
      • 創薬コストの高さ
      • 熟練労働力の不足
    • 市場機会
      • 生物製剤と細胞ベースの治療法の拡大
      • 個別化医療への需要の高まり

第4章 世界の創薬サービス市場産業分析

  • ポーターの5フォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターの5フォース影響分析
  • PEST分析
    • 政治
    • 経済
    • 社会
    • 技術
    • 環境
    • 法律
  • 主な投資機会
  • 主要成功戦略
  • COVID-19影響分析
  • 破壊的動向
  • 業界専門家の視点
  • アナリストの結論・提言

第5章 創薬サービスの世界市場:プロセス別

  • 市場スナップショット
  • 創薬サービスの世界市場:プロセス別、実績 - ポテンシャル分析
  • 創薬サービスの世界市場:プロセス別推定・予測、2020-2030年
  • 創薬サービス市場、サブセグメント分析
    • ターゲット選択
    • ターゲットバリデーション
    • ヒットツーリード同定
    • リードの最適化
    • 候補化合物の検証

第6章 創薬サービスの世界市場:タイプ別

  • 市場スナップショット
  • 創薬サービスの世界市場:タイプ別、実績 - ポテンシャル分析
  • 創薬サービスの世界市場:タイプ別推定・予測、2020-2030年
  • 創薬サービス市場、サブセグメント別分析
    • 化学サービス
    • 生物学サービス

第7章 創薬サービスの世界市場:薬剤タイプ別

  • 市場スナップショット
  • 創薬サービスの世界市場:薬剤タイプ別、実績 - ポテンシャル分析
  • 創薬サービスの世界市場:薬剤タイプ別推定・予測、2020~2030年
  • 創薬サービス市場、サブセグメント分析
    • 低分子医薬品
    • 生物製剤

第8章 創薬サービスの世界市場:治療領域別

  • 市場スナップショット
  • 創薬サービスの世界市場:治療領域別、実績 - ポテンシャル分析
  • 創薬サービスの世界市場:治療領域別推定・予測、2020-2030年
  • 創薬サービス市場、サブセグメント分析
    • がん領域
    • 感染症
    • 神経疾患
    • 免疫疾患
    • 内分泌・代謝疾患
    • 呼吸器系疾患
    • 消化器系疾患
    • 心血管疾患
    • 泌尿器系疾患
    • その他の治療領域

第9章 創薬サービスの世界市場:エンドユーザー別

  • 市場スナップショット
  • 創薬サービスの世界市場:エンドユーザー別、実績 - ポテンシャル分析
  • 創薬サービスの世界市場:エンドユーザー別推定・予測、2020~2030年
  • 創薬サービス市場、サブセグメント分析
    • 製薬・バイオテクノロジー企業
    • 学術機関
    • その他のエンドユーザー

第10章 創薬サービスの世界市場:地域別分析

  • 主要国
  • 主な新興国
  • 創薬サービス市場、地域別市場スナップショット
  • 北米
    • 米国
    • カナダ
  • 欧州創薬サービス市場スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋創薬サービス市場スナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカ創薬サービス市場スナップショット
    • ブラジル
    • メキシコ
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • その他中東とアフリカ

第11章 競合情報

  • 主要企業のSWOT分析
  • 主要市場戦略
  • 企業プロファイル
    • Laboratory Corporation of America Holdings
      • 主要情報
      • 概要
      • 財務(データの入手可能性によります)
      • 製品概要
      • 最近の動向
    • Charles River Laboratories International, Inc.
    • Eurofins Scientific SE
    • GVK Biosciences Private Limited
    • Albany Molecular Research Inc.(AMRI)
    • Domainex Ltd.
    • GenScript Biotech Corporation
    • Aurigene Discovery Technologies Ltd.
    • WuXi AppTec
    • Evotec SE

第12章 調査プロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • 検証
    • 出版
  • 調査属性
  • 調査前提条件
図表

LIST OF TABLES

  • TABLE 1. Global Drug Discovery Services Market, report scope
  • TABLE 2. Global Drug Discovery Services Market estimates & forecasts by Region 2020-2030 (USD Billion)
  • TABLE 3. Global Drug Discovery Services Market estimates & forecasts by Process 2020-2030 (USD Billion)
  • TABLE 4. Global Drug Discovery Services Market estimates & forecasts by Type 2020-2030 (USD Billion)
  • TABLE 5. Global Drug Discovery Services Market estimates & forecasts by Drug Type 2020-2030 (USD Billion)
  • TABLE 6. Global Drug Discovery Services Market estimates & forecasts by Therapeutic Area 2020-2030 (USD Billion)
  • TABLE 7. Global Drug Discovery Services Market estimates & forecasts by End User 2020-2030 (USD Billion)
  • TABLE 8. Global Drug Discovery Services Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 9. Global Drug Discovery Services Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 10. Global Drug Discovery Services Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 11. Global Drug Discovery Services Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 12. Global Drug Discovery Services Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 13. Global Drug Discovery Services Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 14. Global Drug Discovery Services Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 15. Global Drug Discovery Services Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 16. Global Drug Discovery Services Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 17. Global Drug Discovery Services Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 18. U.S. Drug Discovery Services Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 19. U.S. Drug Discovery Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 20. U.S. Drug Discovery Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 21. Canada Drug Discovery Services Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 22. Canada Drug Discovery Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 23. Canada Drug Discovery Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 24. UK Drug Discovery Services Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 25. UK Drug Discovery Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 26. UK Drug Discovery Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 27. Germany Drug Discovery Services Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 28. Germany Drug Discovery Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 29. Germany Drug Discovery Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 30. France Drug Discovery Services Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 31. France Drug Discovery Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 32. France Drug Discovery Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 33. Italy Drug Discovery Services Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 34. Italy Drug Discovery Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 35. Italy Drug Discovery Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 36. Spain Drug Discovery Services Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 37. Spain Drug Discovery Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 38. Spain Drug Discovery Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 39. RoE Drug Discovery Services Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 40. RoE Drug Discovery Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 41. RoE Drug Discovery Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 42. China Drug Discovery Services Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 43. China Drug Discovery Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 44. China Drug Discovery Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 45. India Drug Discovery Services Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 46. India Drug Discovery Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 47. India Drug Discovery Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 48. Japan Drug Discovery Services Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 49. Japan Drug Discovery Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 50. Japan Drug Discovery Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 51. South Korea Drug Discovery Services Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 52. South Korea Drug Discovery Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 53. South Korea Drug Discovery Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 54. Australia Drug Discovery Services Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 55. Australia Drug Discovery Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 56. Australia Drug Discovery Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 57. RoAPAC Drug Discovery Services Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 58. RoAPAC Drug Discovery Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 59. RoAPAC Drug Discovery Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 60. Brazil Drug Discovery Services Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 61. Brazil Drug Discovery Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 62. Brazil Drug Discovery Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 63. Mexico Drug Discovery Services Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 64. Mexico Drug Discovery Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 65. Mexico Drug Discovery Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 66. RoLA Drug Discovery Services Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 67. RoLA Drug Discovery Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 68. RoLA Drug Discovery Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 69. Saudi Arabia Drug Discovery Services Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 70. South Africa Drug Discovery Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 71. RoMEA Drug Discovery Services Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 72. List of secondary sources, used in the study of global Drug Discovery Services Market
  • TABLE 73. List of primary sources, used in the study of global Drug Discovery Services Market
  • TABLE 74. Years considered for the study
  • TABLE 75. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

  • FIG 1. Global Drug Discovery Services Market, research methodology
  • FIG 2. Global Drug Discovery Services Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Drug Discovery Services Market, key trends 2022
  • FIG 5. Global Drug Discovery Services Market, growth prospects 2023-2030
  • FIG 6. Global Drug Discovery Services Market, porters 5 force model
  • FIG 7. Global Drug Discovery Services Market, pest analysis
  • FIG 8. Global Drug Discovery Services Market, value chain analysis
  • FIG 9. Global Drug Discovery Services Market by segment, 2020 & 2030 (USD Billion)
  • FIG 10. Global Drug Discovery Services Market by segment, 2020 & 2030 (USD Billion)
  • FIG 11. Global Drug Discovery Services Market by segment, 2020 & 2030 (USD Billion)
  • FIG 12. Global Drug Discovery Services Market by segment, 2020 & 2030 (USD Billion)
  • FIG 13. Global Drug Discovery Services Market by segment, 2020 & 2030 (USD Billion)
  • FIG 14. Global Drug Discovery Services Market, regional snapshot 2020 & 2030
  • FIG 15. North America Drug Discovery Services Market 2020 & 2030 (USD Billion)
  • FIG 16. Europe Drug Discovery Services Market 2020 & 2030 (USD Billion)
  • FIG 17. Asia pacific Drug Discovery Services Market 2020 & 2030 (USD Billion)
  • FIG 18. Latin America Drug Discovery Services Market 2020 & 2030 (USD Billion)
  • FIG 19. Middle East & Africa Drug Discovery Services Market 2020 & 2030 (USD Billion)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

目次

Global Drug Discovery Services Market is valued approximately USD 17.9 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 14.9% over the forecast period 2023-2030. Drug discovery services encompass a range of scientific and technological solutions provided by specialized organizations to support the identification, development, and optimization of new drug candidates. These services involve various stages of the drug discovery process, including target identification and validation, high-throughput screening, hit-to-lead optimization, medicinal chemistry, ADME (absorption, distribution, metabolism, and excretion) studies, and preclinical development. Through a combination of expertise, advanced technologies, and research methodologies, drug discovery services aim to accelerate the discovery and development of safe and effective drugs, ultimately advancing healthcare and addressing unmet medical needs. The market drivers boosting the market growth are increasing R&D expenditure and growing prevalence of chronic diseases.

According to Statista, in 2022, the total spending on pharmaceutical R&D accounted to USD 238 billion and is expected to amount to USD 285 billion in 2028. The rising incidence of chronic diseases such as cancer, cardiovascular diseases, and neurological disorders has created a significant need for innovative and effective drug therapies. According to Statista, the cancer deaths worldwide are projected to rise from nearly 10 million in 2022 to over 16 million by 2040. Moreover, expansion of Biologics and Cell-Based therapies and increasing demand for personalized medicines may create lucrative opportunities. However, the high cost of Drug Discovery and limited availability of skilled workforce stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Drug Discovery Services Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to a well-established pharmaceutical sector, ongoing research and development projects, significant R&D spending, expansion of the biosimilar and generics markets, and increasing outsourcing of R&D services by pharmaceutical and biopharmaceutical companies in the region. However, Asia Pacific is expected to become the fastest growing during the forecast period, owing to factors such as growing pharmaceutical industry, and increasing outsourcing drug discovery activities to specialized service providers to streamline operations, reduce costs, and access specialized expertise.

Major market player included in this report are:

  • Laboratory Corporation of America Holdings
  • Charles River Laboratories International, Inc.
  • Eurofins Scientific SE
  • GVK Biosciences Private Limited
  • Albany Molecular Research Inc. (AMRI)
  • Domainex Ltd.
  • GenScript Biotech Corporation
  • Aurigene Discovery Technologies Ltd.
  • WuXi AppTec
  • Evotec SE

Recent Developments in the Market:

  • In February 2023, Evotec SE and Related Sciences have extended their collaborative partnership to pursue an integrated multi-target drug discovery agreement. Their joint objective is to identify, research, and advance highly targeted therapies to address unmet medical requirements.
  • In January 2023, Charles River Laboratories completed the acquisition of SAMDI Tech, Inc., a provider of label-free high-throughput screening (HTS) solutions for drug discovery research. This acquisition enhances Charles River Laboratories' capabilities in label-free HTS MS platforms and expands its portfolio of drug discovery solutions, resulting in a comprehensive library of offerings.

Global Drug Discovery Services Market Report Scope:

  • Historical Data: 2020 - 2021
  • Base Year for Estimation: 2022
  • Forecast period: 2023-2030
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Process, Type, Drug Type, Therapeutic Area, End User, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Process:

  • Target Selection
  • Target Validation
  • Hit-to-Lead Identification
  • Lead Optimization
  • Candidate Validation

By Type:

  • Chemistry Services
  • Biology Services

By Drug Type:

  • Small-Molecule Drugs
  • Biologics

By Therapeutic Area:

  • Oncology
  • Infectious Diseases
  • Neurological Diseases
  • Immunological Diseases
  • Endocrine and Metabolic Diseases
  • Respiratory Diseases
  • Digestive System Diseases
  • Cardiovascular Diseases
  • Genitourinary Diseases
  • Other Therapeutic Area

By End User:

  • Pharmaceutical & Biotechnology Companies
  • Academic Institutes
  • Other End Users

By Region:

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Spain
    • Italy
    • ROE
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • RoAPAC
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • Saudi Arabia
    • South Africa
    • Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
    • 1.2.1. Drug Discovery Services Market, by Region, 2020-2030 (USD Billion)
    • 1.2.2. Drug Discovery Services Market, by Process, 2020-2030 (USD Billion)
    • 1.2.3. Drug Discovery Services Market, by Type, 2020-2030 (USD Billion)
    • 1.2.4. Drug Discovery Services Market, by Drug Type, 2020-2030 (USD Billion)
    • 1.2.5. Drug Discovery Services Market, by Therapeutic Area, 2020-2030 (USD Billion)
    • 1.2.6. Drug Discovery Services Market, by End User, 2020-2030 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Drug Discovery Services Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Drug Discovery Services Market Dynamics

  • 3.1. Drug Discovery Services Market Impact Analysis (2020-2030)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing R&D expenditure
      • 3.1.1.2. Growing prevalence of chronic diseases
    • 3.1.2. Market Challenges
      • 3.1.2.1. High Cost of Drug Discovery
      • 3.1.2.2. Limited availability of skilled workforce
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Expansion of Biologics and Cell-Based Therapies
      • 3.1.3.2. Increasing demand for personalized medicine

Chapter 4. Global Drug Discovery Services Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Porter's 5 Force Impact Analysis
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
    • 4.3.5. Environmental
    • 4.3.6. Legal
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. COVID-19 Impact Analysis
  • 4.7. Disruptive Trends
  • 4.8. Industry Expert Perspective
  • 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Drug Discovery Services Market, by Process

  • 5.1. Market Snapshot
  • 5.2. Global Drug Discovery Services Market by Process, Performance - Potential Analysis
  • 5.3. Global Drug Discovery Services Market Estimates & Forecasts by Process 2020-2030 (USD Billion)
  • 5.4. Drug Discovery Services Market, Sub Segment Analysis
    • 5.4.1. Target Selection
    • 5.4.2. Target Validation
    • 5.4.3. Hit-to-Lead Identification
    • 5.4.4. Lead Optimization
    • 5.4.5. Candidate Validation

Chapter 6. Global Drug Discovery Services Market, by Type

  • 6.1. Market Snapshot
  • 6.2. Global Drug Discovery Services Market by Type, Performance - Potential Analysis
  • 6.3. Global Drug Discovery Services Market Estimates & Forecasts by Type 2020-2030 (USD Billion)
  • 6.4. Drug Discovery Services Market, Sub Segment Analysis
    • 6.4.1. Chemistry Services
    • 6.4.2. Biology Services

Chapter 7. Global Drug Discovery Services Market, by Drug Type

  • 7.1. Market Snapshot
  • 7.2. Global Drug Discovery Services Market by Drug Type, Performance - Potential Analysis
  • 7.3. Global Drug Discovery Services Market Estimates & Forecasts by Drug Type 2020-2030 (USD Billion)
  • 7.4. Drug Discovery Services Market, Sub Segment Analysis
    • 7.4.1. Small-Molecule Drugs
    • 7.4.2. Biologics

Chapter 8. Global Drug Discovery Services Market, by Therapeutic Area

  • 8.1. Market Snapshot
  • 8.2. Global Drug Discovery Services Market by Therapeutic Area, Performance - Potential Analysis
  • 8.3. Global Drug Discovery Services Market Estimates & Forecasts by Therapeutic Area 2020-2030 (USD Billion)
  • 8.4. Drug Discovery Services Market, Sub Segment Analysis
    • 8.4.1. Oncology
    • 8.4.2. Infectious Diseases
    • 8.4.3. Neurological Diseases
    • 8.4.4. Immunological Diseases
    • 8.4.5. Endocrine and Metabolic Diseases
    • 8.4.6. Respiratory Diseases
    • 8.4.7. Digestive System Diseases
    • 8.4.8. Cardiovascular Diseases
    • 8.4.9. Genitourinary Diseases
    • 8.4.10. Other Therapeutic Area

Chapter 9. Global Drug Discovery Services Market, by End User

  • 9.1. Market Snapshot
  • 9.2. Global Drug Discovery Services Market by End User, Performance - Potential Analysis
  • 9.3. Global Drug Discovery Services Market Estimates & Forecasts by End User 2020-2030 (USD Billion)
  • 9.4. Drug Discovery Services Market, Sub Segment Analysis
    • 9.4.1. Pharmaceutical & Biotechnology Companies
    • 9.4.2. Academic Institutes
    • 9.4.3. Other End Users

Chapter 10. Global Drug Discovery Services Market, Regional Analysis

  • 10.1. Top Leading Countries
  • 10.2. Top Emerging Countries
  • 10.3. Drug Discovery Services Market, Regional Market Snapshot
  • 10.4. North America Drug Discovery Services Market
    • 10.4.1. U.S. Drug Discovery Services Market
      • 10.4.1.1. Process breakdown estimates & forecasts, 2020-2030
      • 10.4.1.2. Type breakdown estimates & forecasts, 2020-2030
      • 10.4.1.3. Drug Type breakdown estimates & forecasts, 2020-2030
      • 10.4.1.4. Therapeutic Area breakdown estimates & forecasts, 2020-2030
      • 10.4.1.5. End User breakdown estimates & forecasts, 2020-2030
    • 10.4.2. Canada Drug Discovery Services Market
  • 10.5. Europe Drug Discovery Services Market Snapshot
    • 10.5.1. U.K. Drug Discovery Services Market
    • 10.5.2. Germany Drug Discovery Services Market
    • 10.5.3. France Drug Discovery Services Market
    • 10.5.4. Spain Drug Discovery Services Market
    • 10.5.5. Italy Drug Discovery Services Market
    • 10.5.6. Rest of Europe Drug Discovery Services Market
  • 10.6. Asia-Pacific Drug Discovery Services Market Snapshot
    • 10.6.1. China Drug Discovery Services Market
    • 10.6.2. India Drug Discovery Services Market
    • 10.6.3. Japan Drug Discovery Services Market
    • 10.6.4. Australia Drug Discovery Services Market
    • 10.6.5. South Korea Drug Discovery Services Market
    • 10.6.6. Rest of Asia Pacific Drug Discovery Services Market
  • 10.7. Latin America Drug Discovery Services Market Snapshot
    • 10.7.1. Brazil Drug Discovery Services Market
    • 10.7.2. Mexico Drug Discovery Services Market
  • 10.8. Middle East & Africa Drug Discovery Services Market
    • 10.8.1. Saudi Arabia Drug Discovery Services Market
    • 10.8.2. South Africa Drug Discovery Services Market
    • 10.8.3. Rest of Middle East & Africa Drug Discovery Services Market

Chapter 11. Competitive Intelligence

  • 11.1. Key Company SWOT Analysis
    • 11.1.1. Company 1
    • 11.1.2. Company 2
    • 11.1.3. Company 3
  • 11.2. Top Market Strategies
  • 11.3. Company Profiles
    • 11.3.1. Laboratory Corporation of America Holdings
      • 11.3.1.1. Key Information
      • 11.3.1.2. Overview
      • 11.3.1.3. Financial (Subject to Data Availability)
      • 11.3.1.4. Product Summary
      • 11.3.1.5. Recent Developments
    • 11.3.2. Charles River Laboratories International, Inc.
    • 11.3.3. Eurofins Scientific SE
    • 11.3.4. GVK Biosciences Private Limited
    • 11.3.5. Albany Molecular Research Inc. (AMRI)
    • 11.3.6. Domainex Ltd.
    • 11.3.7. GenScript Biotech Corporation
    • 11.3.8. Aurigene Discovery Technologies Ltd.
    • 11.3.9. WuXi AppTec
    • 11.3.10. Evotec SE

Chapter 12. Research Process

  • 12.1. Research Process
    • 12.1.1. Data Mining
    • 12.1.2. Analysis
    • 12.1.3. Market Estimation
    • 12.1.4. Validation
    • 12.1.5. Publishing
  • 12.2. Research Attributes
  • 12.3. Research Assumption